seqWell was created to revolutionize NGS library prep to unlock the full potential of today's DNA sequencing instruments. Building on core strengths of molecular reagent design and workflow engineering, seqWell's product portfolio allows improvements in the scale and quality of DNA sequencing results. Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes.
In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking.
Joseph Mellor, PhD Founder and Chief Executive Officer
Erick Suh Chief Commercial Officer
Jack T. Leonard, PhD Chief Technology Officer
Tom Grant Chief Financial Officer
Kerri Stellato Vice President, Sales & Marketing
Chris Boggess Vice President, Business Development
Ariele Hanek, PhD Director, Research and Development
Matt Parisi Director, Operations
Fritz Roth, PhD Professor, University of Toronto
Corey Nislow, PhD Professor, University of British Columbia
Marc Vidal, PhD Professor, Harvard Medical School and Dana-Farber Cancer Institute